Geneva, July 20 -- International Clinical Trials Registry received information related to the study (EUCTR2025-000541-19-Outside-EU/EEA) titled 'Safety and Immunogenicity of NVX-CoV2705' on July 8.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: no Randomised: no Open: yes Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Other: no Number of treatment arms in the trial: 2
Primary Sponsor: Sanofi Vaccines US Inc.
Condition:
Severe acute respiratory syndrome coronavirus 2
MedDRA version: 23.0
Level: PT
Classification code 10051905
Term: Coronavirus infection
System Organ Class: 10021881 - In...